Cargando…

Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model

Pneumocystis pneumonia is a severe lung infection that occurs primarily in largely immunocompromised patients. Few treatment options exist, and the mortality rate remains substantial. To develop new strategies in the fields of diagnosis and treatment, it appears to be critical to improve the scienti...

Descripción completa

Detalles Bibliográficos
Autores principales: Chesnay, Adélaïde, Paget, Christophe, Heuzé-Vourc’h, Nathalie, Baranek, Thomas, Desoubeaux, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877242/
https://www.ncbi.nlm.nih.gov/pubmed/35205883
http://dx.doi.org/10.3390/jof8020129
_version_ 1784658373747146752
author Chesnay, Adélaïde
Paget, Christophe
Heuzé-Vourc’h, Nathalie
Baranek, Thomas
Desoubeaux, Guillaume
author_facet Chesnay, Adélaïde
Paget, Christophe
Heuzé-Vourc’h, Nathalie
Baranek, Thomas
Desoubeaux, Guillaume
author_sort Chesnay, Adélaïde
collection PubMed
description Pneumocystis pneumonia is a severe lung infection that occurs primarily in largely immunocompromised patients. Few treatment options exist, and the mortality rate remains substantial. To develop new strategies in the fields of diagnosis and treatment, it appears to be critical to improve the scientific knowledge about the biology of the Pneumocystis agent and the course of the disease. In the absence of in vitro continuous culture system, in vivo animal studies represent a crucial cornerstone for addressing Pneumocystis pneumonia in laboratories. Here, we provide an overview of the animal models of Pneumocystis pneumonia that were reported in the literature over the last 60 years. Overall, this review highlights the great heterogeneity of the variables studied: the choice of the host species and its genetics, the different immunosuppressive regimens to render an animal susceptible, the experimental challenge, and the different validation methods of the model. With this work, the investigator will have the keys to choose pivotal experimental parameters and major technical features that are assumed to likely influence the results according to the question asked. As an example, we propose an animal model to explore the immune response during Pneumocystis pneumonia.
format Online
Article
Text
id pubmed-8877242
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88772422022-02-26 Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model Chesnay, Adélaïde Paget, Christophe Heuzé-Vourc’h, Nathalie Baranek, Thomas Desoubeaux, Guillaume J Fungi (Basel) Review Pneumocystis pneumonia is a severe lung infection that occurs primarily in largely immunocompromised patients. Few treatment options exist, and the mortality rate remains substantial. To develop new strategies in the fields of diagnosis and treatment, it appears to be critical to improve the scientific knowledge about the biology of the Pneumocystis agent and the course of the disease. In the absence of in vitro continuous culture system, in vivo animal studies represent a crucial cornerstone for addressing Pneumocystis pneumonia in laboratories. Here, we provide an overview of the animal models of Pneumocystis pneumonia that were reported in the literature over the last 60 years. Overall, this review highlights the great heterogeneity of the variables studied: the choice of the host species and its genetics, the different immunosuppressive regimens to render an animal susceptible, the experimental challenge, and the different validation methods of the model. With this work, the investigator will have the keys to choose pivotal experimental parameters and major technical features that are assumed to likely influence the results according to the question asked. As an example, we propose an animal model to explore the immune response during Pneumocystis pneumonia. MDPI 2022-01-27 /pmc/articles/PMC8877242/ /pubmed/35205883 http://dx.doi.org/10.3390/jof8020129 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Chesnay, Adélaïde
Paget, Christophe
Heuzé-Vourc’h, Nathalie
Baranek, Thomas
Desoubeaux, Guillaume
Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model
title Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model
title_full Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model
title_fullStr Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model
title_full_unstemmed Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model
title_short Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model
title_sort pneumocystis pneumonia: pitfalls and hindrances to establishing a reliable animal model
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877242/
https://www.ncbi.nlm.nih.gov/pubmed/35205883
http://dx.doi.org/10.3390/jof8020129
work_keys_str_mv AT chesnayadelaide pneumocystispneumoniapitfallsandhindrancestoestablishingareliableanimalmodel
AT pagetchristophe pneumocystispneumoniapitfallsandhindrancestoestablishingareliableanimalmodel
AT heuzevourchnathalie pneumocystispneumoniapitfallsandhindrancestoestablishingareliableanimalmodel
AT baranekthomas pneumocystispneumoniapitfallsandhindrancestoestablishingareliableanimalmodel
AT desoubeauxguillaume pneumocystispneumoniapitfallsandhindrancestoestablishingareliableanimalmodel